-
1
-
-
43449116727
-
Infection in burn patients
-
Cohen J., and Powderly W. (Eds), Mosby International, London
-
Barillo D.J., and McManus A.T. Infection in burn patients. In: Cohen J., and Powderly W. (Eds). Infectious diseases. 2nd ed. (2003), Mosby International, London
-
(2003)
Infectious diseases. 2nd ed.
-
-
Barillo, D.J.1
McManus, A.T.2
-
3
-
-
0000182562
-
Un neuroleptique majeur non pehonthiazin et non resepenique, l'haperidol, dans le traitement des psychoses
-
Delay J., Pichot P., and Lemperiere T. Un neuroleptique majeur non pehonthiazin et non resepenique, l'haperidol, dans le traitement des psychoses. Ann Med Psychol 118 (1960) 145-152
-
(1960)
Ann Med Psychol
, vol.118
, pp. 145-152
-
-
Delay, J.1
Pichot, P.2
Lemperiere, T.3
-
4
-
-
0024494998
-
Mortality from neuroleptic malignant syndrome
-
Shalev A., Hermesh H., and Munitz H. Mortality from neuroleptic malignant syndrome. J Clin Psychiatry 50 (1989) 18-25
-
(1989)
J Clin Psychiatry
, vol.50
, pp. 18-25
-
-
Shalev, A.1
Hermesh, H.2
Munitz, H.3
-
5
-
-
0027531002
-
Neuroleptic malignant syndrome
-
Caroff S.N., and Mann S.C. Neuroleptic malignant syndrome. Med Clin N Am 77 (1993) 185-202
-
(1993)
Med Clin N Am
, vol.77
, pp. 185-202
-
-
Caroff, S.N.1
Mann, S.C.2
-
7
-
-
0034263460
-
assessment and management of neuroleptic malignant syndrome
-
Khan M., Farver D., and Recognition. assessment and management of neuroleptic malignant syndrome. South Dakota J Med 53 (2000) 395-400
-
(2000)
South Dakota J Med
, vol.53
, pp. 395-400
-
-
Khan, M.1
Farver, D.2
Recognition3
-
8
-
-
0035025971
-
Neuroleptic malignant syndrome in children and adolescents
-
Ty E.B., and David Rothner A. Neuroleptic malignant syndrome in children and adolescents. J Child Neurol 16 (2001) 157-163
-
(2001)
J Child Neurol
, vol.16
, pp. 157-163
-
-
Ty, E.B.1
David Rothner, A.2
-
9
-
-
0019253114
-
Biochemical and neuroendocrine approaches to a malignant syndrome of neuroleptics
-
Asseau M., Diricq S.T., Grisar T.H., and Collard J. Biochemical and neuroendocrine approaches to a malignant syndrome of neuroleptics. Acta Psychiatr Belg 80 (1986) 600-606
-
(1986)
Acta Psychiatr Belg
, vol.80
, pp. 600-606
-
-
Asseau, M.1
Diricq, S.T.2
Grisar, T.H.3
Collard, J.4
-
10
-
-
0022636827
-
A role of catecholamines in the pathogenesis of the neuroleptic malignant syndrome
-
Schibuck M., and Schacter D. A role of catecholamines in the pathogenesis of the neuroleptic malignant syndrome. Can J Psychiatry 31 (1986) 66-69
-
(1986)
Can J Psychiatry
, vol.31
, pp. 66-69
-
-
Schibuck, M.1
Schacter, D.2
-
11
-
-
0022370639
-
Neuroleptic malignant syndrome
-
Levenson J.L. Neuroleptic malignant syndrome. Am J Psychiatry 142 (1985) 1137-1145
-
(1985)
Am J Psychiatry
, vol.142
, pp. 1137-1145
-
-
Levenson, J.L.1
-
12
-
-
0004114405
-
-
Am Psychiatric Press, Inc, Washington, DC
-
Lazarus A., Mann S.C., and Caroff S.N. The neuroleptic malignant syndrome and related conditions (1989), Am Psychiatric Press, Inc, Washington, DC
-
(1989)
The neuroleptic malignant syndrome and related conditions
-
-
Lazarus, A.1
Mann, S.C.2
Caroff, S.N.3
-
13
-
-
33745188732
-
Chlorpromazine-induced neuroleptic malignant syndrome
-
Lew T.Y., and Tollefson G. Chlorpromazine-induced neuroleptic malignant syndrome. Can J Psychiatry 31 (1986) 66-69
-
(1986)
Can J Psychiatry
, vol.31
, pp. 66-69
-
-
Lew, T.Y.1
Tollefson, G.2
-
14
-
-
0033021534
-
Sympathadrenal hyperactivity and the etiology of neuroleptic malignant syndrome
-
Gurrera R.J. Sympathadrenal hyperactivity and the etiology of neuroleptic malignant syndrome. Am J Psychiatry 156 (1999) 169-180
-
(1999)
Am J Psychiatry
, vol.156
, pp. 169-180
-
-
Gurrera, R.J.1
|